Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Innovative new cancer drug enters the first phase of clinical trials

Innovative new cancer drug enters the first phase of clinical trials

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

FDA approves new drug for bone marrow disease

FDA approves new drug for bone marrow disease

Drug combo effective for advanced breast cancer

Drug combo effective for advanced breast cancer

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

Chromosome losses can signal an especially poor response to therapy

Chromosome losses can signal an especially poor response to therapy

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

New research center created by leading blood and marrow transplant organizations

New research center created by leading blood and marrow transplant organizations

Bone marrow and stem cell transplantation rejection averted by UV light exposure

Bone marrow and stem cell transplantation rejection averted by UV light exposure

West Nile treatment showing 100% response rate among immunocompetent patients

West Nile treatment showing 100% response rate among immunocompetent patients

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

World's first gene therapy trial aimed at preventing cancer

World's first gene therapy trial aimed at preventing cancer

Embryo testing could produce babies who might aid sick siblings

Embryo testing could produce babies who might aid sick siblings

Bush on healthcare

Bush on healthcare

Developing smart drugs

Developing smart drugs

Transplanted bone-marrow cells could regenerate nerve cells in the brain

Transplanted bone-marrow cells could regenerate nerve cells in the brain

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

FDA approval for Cladribine to treat active Hairy Cell Leukemia

FDA approval for Cladribine to treat active Hairy Cell Leukemia

Stem Cell Institute will call on expertise from around University to turn research into therapy

Stem Cell Institute will call on expertise from around University to turn research into therapy